Sidebar

At this stage of the game I wouldn't expect much from the major shareholders. They have all dumped sizable amounts into this project and imho  expected  BOM to take it over the top. That didn't happen, although the btd gave apb an inside track. There have been numerous published studies of results as detailed in the MDA just released. RVX is on the block - question is - is it far enough along for a sale and does it fit in the long term plans of any BP. The last quarter was funded by DM and relatives or friends - DM is keeping this thing afloat right now - problem is he doesnt have deep enough pockets. The vultures are circling - Hepa obligation is due mid 2023 - again, is apb far enough along and promising enough for a sale?

jmo 

Chicagoest

.